Medication info

Bazetamind Tablet

Prescription medicationApproval withdrawn
Ingredient · strength
Bazedoxifene Acetate›Strength being verifiedCholecalciferol Concentrate Powder›Strength being verified
Manufacturer / importer
Boryung Pharmaceutical Co., Ltd.
Appearance
Pink rectangular film-coated tablet
Packaging
28 tablets (28 tablets/PTP)
Approval status
Approval withdrawn

MFDS item code 201804131 · Approved 2018.10.18

This product's status changed to Approval withdrawn on 2023.07.24. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment and prevention of osteoporosis in postmenopausal women
Who uses it
Adults
Adult dosage
Take 1 tablet once daily, with or without food. If the patient's dietary intake of calcium and vitamin D is insufficient, supplements should be taken. Patients with renal impairment: This drug has not been adequately evaluated in patients with severe renal impairment and should be administered with caution. Patients with hepatic impairment: Use of this drug is not recommended in patients with hepatic impairment because its safety and efficacy have not been established.

Ingredients

Manufacturer
Boryung Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment and prevention of osteoporosis in postmenopausal women

  • Osteoporosis in postmenopausal women
View approved original text

This medicine is used to treat and prevent osteoporosis in postmenopausal women. It is primarily effective in reducing the incidence of spinal fractures; however, its clear efficacy for non-spinal fractures has not yet been established. Therefore, this medicine helps protect spinal health in postmenopausal women and improves symptoms of osteoporosis.

Dosage and Administration

Adult dosage

Take 1 tablet once daily, with or without food. If the patient's dietary intake of calcium and vitamin D is insufficient, supplements should be taken. Patients with renal impairment: This drug has not been adequately evaluated in patients with severe renal impairment and should be administered with caution. Patients with hepatic impairment: Use of this drug is not recommended in patients with hepatic impairment because its safety and efficacy have not been established.

Precautions

This medicine may increase the risk of venous thromboembolism, which is the formation of blood clots in the blood vessels. Conditions such as deep vein thrombosis, pulmonary embolism, and retinal vein thrombosis may occur, so it is not recommended for women at high risk for thrombosis. Patients who are immobile should be aware that they must stop taking this medication and can resume it once they are able to move again. Additionally, during long trips, it is important to move regularly to reduce the risk of thrombosis. This medication is intended only for postmenopausal women and should not be used by premenopausal women, pregnant women, or nursing mothers. Patients with uterine bleeding or symptoms of endometrial cancer, as well as those with certain metabolic disorders, should also avoid this medication. Patients with poor liver or kidney function, hypertriglyceridemia, and those taking certain medications should use this drug cautiously, and dosage adjustments may be necessary under the guidance of a physician. Possible side effects during the use of this medication include facial flushing due to vasodilation, leg cramps, dry mouth, rash, itching, muscle cramps, peripheral edema, elevations in blood triglycerides, increases in alanine aminotransferase (ALT), increases in aspartate aminotransferase (AST), vision changes, blurred vision, photophobia, visual field defects, visual impairment, dry eyes, eyelid swelling, eyelid twitching, eye pain, eye swelling, vomiting, gastritis, colon polyps, belching, and allergies. If symptoms such as changes in vision or eye pain and swelling occur, immediate medical attention is required. It is advisable to take calcium supplements if calcium intake is insufficient during treatment, as well as additional vitamin D supplementation for elderly individuals or those with chronic diseases who are at a greater risk of vitamin D deficiency. Caution is needed for driving or operating machinery as dizziness or visual disturbances may occur. In cases of overdose, there is no specific antidote, so treatment should be symptomatic. Symptoms such as hypercalcemia or kidney stones may arise, so blood and urine tests should be performed to monitor the patient's condition. This medication should not be used in children, and it should be stored out of reach of children in its original container with the lid tightly closed.

Side effects

Hypersensitivity, drowsiness, retinal vein thrombosis, facial flushing, deep vein thrombosis, superficial thrombophlebitis, pulmonary embolism, dry mouth, hives, rash, itching, muscle cramps, peripheral edema, increased serum triglycerides, elevated alanine aminotransferase, elevated aspartate aminotransferase, vision impairment, blurred vision, photopsia, visual field defect, visual impairment, dry eye syndrome, eyelid edema, eyelid spasm, eye pain, eye swelling, vomiting, gastritis, colon polyps, belching, death, fever, systemic edema, fatigue, allergic reactions, chest discomfort, leg pain, edema, facial edema, changes in temperature sensation, malaise, weakness, inadequate effect, dermatitis, localized skin reactions, increased sweating, eczema, hair loss, back pain, joint pain, muscle weakness, shoulder rotator cuff syndrome, headache, dizziness, pharyngitis, pyelonephritis, palpitations, cerebral infarction, intracerebral hemorrhage, pyelonephritis, bradycardia, respiratory failure, biliary stones, increased alkaline phosphatase, hepatic cyst, hepatocyte damage, weight gain, hyperlipidemia, central obesity, dysuria, urinary abnormalities, renal cyst, urinary incontinence, vaginal bleeding, breast congestion, insomnia, leukocytosis, laceration, bruise, nausea, abdominal pain, constipation, diarrhea, psychological symptoms, altered consciousness, headache, nausea, loss of appetite, weight loss, increased thirst, arrhythmia, increased urinary frequency, kidney stones, renal calcification, calcification in peripheral tissues of the bone, myalgia, arthralgia

Not everyone experiences these, and they can vary from person to person.

Storage

This medicine should be stored in a tightly closed container to prevent exposure to air or moisture. It is best to maintain the storage temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

Pink rectangular film-coated tablet

Package unit

28 tablets (28 tablets/PTP)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.